LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.95 | 21.74 | 2 | 1354 | 0.0015 | -0.3298 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.95 | 21.74 | 975 | 1354 | 0.7198 | 0.8927 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.92 | 21.74 | 4 | 1515 | 0.0026 | -0.2415 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.92 | 21.74 | 750 | 1515 | 0.4948 | 0.7829 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.92 | 21.74 | 7 | 1515 | 0.0046 | -0.1690 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.92 | 21.74 | 986 | 1515 | 0.6506 | 0.8644 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.89 | 21.74 | 6 | 1677 | 0.0036 | -0.1856 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.89 | 21.74 | 760 | 1677 | 0.4532 | 0.7628 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.89 | 21.74 | 7 | 1677 | 0.0042 | -0.1654 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 27.89 | 21.74 | 975 | 1677 | 0.5814 | 0.8343 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.86 | 21.74 | 14 | 1887 | 0.0074 | -0.0661 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.86 | 21.74 | 762 | 1887 | 0.4038 | 0.7373 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.86 | 21.74 | 4 | 1887 | 0.0021 | -0.2312 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 29.86 | 21.74 | 973 | 1887 | 0.5156 | 0.8045 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.83 | 21.74 | 26 | 2110 | 0.0123 | 0.0275 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.83 | 21.74 | 750 | 2110 | 0.3555 | 0.7099 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.83 | 21.74 | 4 | 2110 | 0.0019 | -0.2262 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 31.83 | 21.74 | 950 | 2110 | 0.4502 | 0.7723 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.80 | 21.74 | 47 | 2381 | 0.0197 | 0.1205 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.80 | 21.74 | 752 | 2381 | 0.3158 | 0.6871 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.80 | 21.74 | 6 | 2381 | 0.0025 | -0.1731 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 33.80 | 21.74 | 935 | 2381 | 0.3926 | 0.7422 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.77 | 21.74 | 63 | 2602 | 0.0242 | 0.1666 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.77 | 21.74 | 751 | 2602 | 0.2885 | 0.6705 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 35.77 | 21.74 | 2 | 2602 | 0.0008 | -0.2922 | MN20160310_N01 | K20 |